OptoBarrier: An Optogenetic Platform for Modulating Endothelial Barriers In Vitro
ACS Biomaterials Science & Engineering · 2025
DOI: 10.1021/acsbiomaterials.5c00708 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2025. Verfasst von Sharon Fleischer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Columbia University, New York, New York 10032, United States. Hauptthemen laut MEDLINE: Optogenetics, Endothelial Cells, Lab-On-A-Chip Devices. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Directorate for Biological Sciences, National Heart, Lung, and Blood Institute, National Institute of Biomedical Imaging and Bioengineering.
Abstract (Originalsprache)
Organ-on-a-chip platforms have emerged as promising human tissue models for drug screening and mechanistic studies, offering alternatives to traditional animal models. Integration of vascular structures into these platforms is pivotal for creating physiologically faithful models of individual organs and studying interorgan crosstalk. However, most vascular structures grown in vitro do not account for organ-specific endothelial permeability or its modulation in response to disease. Here, we present optoBarrier, an optogenetic organ-on-a-chip platform designed to modulate endothelial barrier permeability through light stimulation. By optically activating RhoA signaling in engineered optogenetic endothelial cells, we demonstrate the formation of stress fibers, disruption of vascular endothelial cadherin (VE-cadherin) and increased barrier permeability. We further show that permeability is tunable in a reversible and dose-dependent manner in response to light. We therefore propose that optoBarrier offers a user-defined, controlled and simple method to manipulate endothelial permeability for in vitro studies of human vasculature.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Columbia University, New York, New York 10032, United States.
- Department of Medicine, Columbia University, New York, New York 10032, United States.
- College of Dental Medicine, Columbia University, New York, New York 10032, United States.
ORCID-Profile: Sharon Fleischer, Martin Liberman, Trevor R Nash, Gordana Vunjak-Novakovic
Förderung
- Directorate for Biological Sciences
- National Heart, Lung, and Blood Institute
- National Institute of Biomedical Imaging and Bioengineering
Zitieren
APA
Fleischer, S., Liberman, M., Summers, M., Li, V., Nash, T. R., & Vunjak-Novakovic, G. (2025). OptoBarrier: An Optogenetic Platform for Modulating Endothelial Barriers In Vitro. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c00708
Vancouver
Fleischer S, Liberman M, Summers M, Li V, Nash TR, Vunjak-Novakovic G. OptoBarrier: An Optogenetic Platform for Modulating Endothelial Barriers In Vitro. ACS Biomaterials Science & Engineering. 2025. doi:10.1021/acsbiomaterials.5c00708
BibTeX
@article{Fleischer2025,
author = {Fleischer, Sharon and Liberman, Martin and Summers, Max and Li, Vanessa and Nash, Trevor R and Vunjak-Novakovic, Gordana},
title = {OptoBarrier: An Optogenetic Platform for Modulating Endothelial Barriers In Vitro},
journal = {ACS Biomaterials Science & Engineering},
year = {2025},
doi = {10.1021/acsbiomaterials.5c00708}
}
EUVIMED